FDA Approves First Alzheimer’s Drug in Years | Venice Beach News

FDA just approved Lecanemab, a groundbreaking Alzheimer’s drug that slows cognitive decline by clearing brain amyloid plaques—offering hope to millions, though it comes with risks and hefty costs. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/beba1f13773adb67